MYC and chronic myelogenous leukemia, BCR-ABL1 positive: In CML MYC-overexpressing cells, the MYC:MAX heterodimer was found to bind to BCR promoter region in four binding sites, leading to upregulation of both BCR and the fusion protein at mRNA and protein level.